Stocksigma LogoStocksigma Logo

Indoco Remedies Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Indoco Remedies Limited has scheduled a meeting of its Board of Directors on 27th Oct'26 to consider and approve the un-audited standalone and consolidated

Indoco Remedies Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Indoco Remedies Ltd 路 Intimation 路 27 Oct 2026, 5:30 am

Indoco Remedies Schedules Board Meeting to Approve Q2 and H1 FY27 Results Indoco Remedies Limited has scheduled a meeting of its Board of Directors on 27th Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. Consequently, the trading window for dealing in the company's equity shares remains closed for designated persons and their immediate relatives until 29th Oct'26, concluding 48 hours post the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Indoco Remedies Ltd

All Indoco Remedies Ltd announcements